mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0005 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |